NCT03719105 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT03719105
Title	Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma
Recruitment	Recruiting
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	New York Medical College
Indications	mature T-cell and NK-cell lymphoma angioimmunoblastic T-cell lymphoma aggressive NK-cell leukemia peripheral T-cell lymphoma
Therapies	Pembrolizumab Brentuximab vedotin + Cyclophosphamide + Doxorubicin + Pralatrexate + Prednisone Calaspargase pegol-mknl + Dexamethasone + Etoposide + Ifosfamide + Methotrexate
Age Groups:	adult \| child
Covered Countries	USA

NCT03719105
Clinical Trial Detail